Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Interest Expenses (2019 - 2025)

Outset Medical (OM) has disclosed Interest Expenses for 7 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 40.93% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.0 million, a 41.55% decrease, with the full-year FY2025 number at $14.0 million, down 41.55% from a year prior.
  • Interest Expenses was $3.4 million for Q4 2025 at Outset Medical, down from $3.5 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $6.1 million in Q3 2024 to a low of $422000.0 in Q1 2021.
  • A 5-year average of $2.8 million and a median of $3.2 million in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: crashed 58.24% in 2021, then soared 597.16% in 2023.
  • Outset Medical's Interest Expenses stood at $431000.0 in 2021, then surged by 386.31% to $2.1 million in 2022, then surged by 63.02% to $3.4 million in 2023, then soared by 70.47% to $5.8 million in 2024, then crashed by 40.93% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Interest Expenses are $3.4 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025).